Brickell Biotech hires new chief medical officer
BOULDER — Brickell Biotech Inc. (Nasdaq: BII) has hired a new chief medical officer.
In filings with the U.S. Securities and Exchange Commission, the Boulder skin care drugmaker announced it had hired Sanjeev Ahuja, currently chief medical officer at Carmel, Indiana-based rare disease drugmaker Celtaxsys Inc., to lead the company’s product development. The contract shows he will make $387,500 annually and up to 35 percent of that base salary per year in performance bonuses.
Ahuja’s hiring comes a little over a month after Brickell completed a reverse initial public offering by acquiring San Diego-based gene therapy company Vical Inc. and taking over its stock ticker on the Nasdaq exchange.
SPONSORED CONTENT
Business Cares: March 2024
WomenGive, a program of United Way of Larimer County, was started in Larimer County in 2006 as an opportunity for women in our community to come together to help other women.
Ahuja starts on Oct. 15.
BOULDER — Brickell Biotech Inc. (Nasdaq: BII) has hired a new chief medical officer.
In filings with the U.S. Securities and Exchange Commission, the Boulder skin care drugmaker announced it had hired Sanjeev Ahuja, currently chief medical officer at Carmel, Indiana-based rare disease drugmaker Celtaxsys Inc., to lead the company’s product development. The contract shows he will make $387,500 annually and up to 35 percent of that base salary per year in performance bonuses.
Ahuja’s hiring comes a little over a month after Brickell completed a reverse initial public offering by acquiring San Diego-based gene therapy…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!